NASDAQ:MSON - Misonix Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$17.25 -0.25 (-1.43 %)
(As of 08/20/2018 06:37 AM ET)
Previous Close$17.50
Today's Range$17.25 - $17.50
52-Week Range$8.25 - $18.25
Volume4,815 shs
Average Volume13,784 shs
Market Capitalization$163.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.27
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Debt-to-Equity RatioN/A
Current Ratio5.48
Quick Ratio4.24

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$27.27 million
Price / Sales5.95
Cash FlowN/A
Price / CashN/A
Book Value$3.12 per share
Price / Book5.53

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-1,680,000.00
Net Margins-17.36%
Return on Equity-1.68%
Return on Assets-1.42%

Miscellaneous

Employees92
Outstanding Shares9,400,000
Market Cap$163.17 million

Misonix (NASDAQ:MSON) Frequently Asked Questions

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings data on Monday, May, 7th. The medical equipment provider reported $0.23 earnings per share for the quarter. The medical equipment provider had revenue of $12.44 million for the quarter. Misonix had a negative return on equity of 1.68% and a negative net margin of 17.36%. View Misonix's Earnings History.

When is Misonix's next earnings date?

Misonix is scheduled to release their next quarterly earnings announcement on Tuesday, August, 28th 2018. View Earnings Estimates for Misonix.

Who are some of Misonix's key competitors?

Who are Misonix's key executives?

Misonix's management team includes the folowing people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 48)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 62)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 51)
  • Mr. Richard A. Zaremba, Special Projects Mang. (Age 63)
  • Mr. Dan Voic, VP of R&D and Engineering (Age 56)

Has Misonix been receiving favorable news coverage?

News stories about MSON stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Misonix earned a news impact score of 0.13 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 47.89 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for Misonix.

Who are Misonix's major shareholders?

Misonix's stock is owned by a number of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (4.01%), Renaissance Technologies LLC (2.23%), WealthTrust Axiom LLC (0.44%) and BlackRock Inc. (0.27%). Company insiders that own Misonix stock include Joseph P Dwyer, Patrick A Mcbrayer, Stavros G Vizirgianakis and Thomas M Patton. View Institutional Ownership Trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including WealthTrust Axiom LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for Misonix.

Which institutional investors are buying Misonix stock?

MSON stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and BlackRock Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer, Stavros G Vizirgianakis and Thomas M Patton. View Insider Buying and Selling for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $17.25.

How big of a company is Misonix?

Misonix has a market capitalization of $163.17 million and generates $27.27 million in revenue each year. Misonix employs 92 workers across the globe.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (NASDAQ MSON)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  122
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: Diversification

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel